The focus of the seminar delivered by members of our corporate finance and life sciences teams will be the biotech sector. The speakers assisted the UK BioIndustry Association in producing its recent guide to investing in the UK Biotech sector.
Agenda
Is AIM the ‘new Nasdaq’ for biotechs? – this session examines the positive impact of the pandemic on the biotech sector
The power of AI and Data – realising the full potential of AI and data and how it can be used to drive commercial value
Understanding the value of intellectual property – what to look out for when investing and how companies deploy IP to ensure competitive advantage
M&A and the future of the supply chain – an insight into emerging trends
Event date
08.30-09.15
Please register or sign-in to view the recording from this event
We use cookies that are essential for our site to work. To improve our site, we would like to use additional cookies to help us understand how visitors use it, measure traffic to our site from social media platforms and to personalise your experience. Some of the cookies that we use are provided by third parties. To accept all cookies click ‘accept all’. To reject all optional cookies click ‘reject all’. To choose which optional cookies to allow click ‘cookie settings’. This tool uses a cookie to remember your choices.
Please visit our cookie policy for more information.
We are processing your request. \n Thank you for your patience.An error occurred. This could be due to inactivity on the page - please try again.